Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study) (clinicaltrials.gov) - Oct 9, 2026 - P2 | N=218 | Recruiting | Sponsor: Melanoma Institute Australia | Trial primary completion date: Aug 2026 ➔ Dec 2026
Trial primary completion date • Melanoma • Oncology • Solid Tumor • BRAF
|